Risk of Severe Hyperglycemia Following Systemic Corticosteroids and Azithromycin Use in COVID-19 Patients with Type 2 Diabetes: A Sequential Surveillance Analysis

In this request, we assessed the comparative risk of severe hyperglycemia in COVID-19 patients with type 2 diabetes treated with systemic corticosteroids and azithromycin compared to COVID-19 patients treated with azithromycin alone. This analysis contains two reports:

• Report 1: This report contains the results of the first analysis or "look" in a sequential analysis. The study period includes data from May 1, 2021 to August 31, 2023. We distributed this request to five Sentinel Data Partners on February 14, 2024. 
• Report 2: This report contains the results of the second analysis or "look" of a sequential analysis. The study period includes data from May 1, 2021 to October 1, 2023. We distributed this request to five Sentinel Data Partners on July 26, 2024.